BR100 Increased By (0.39%)
BR30 Increased By (0.47%)
KSE100 Increased By (0.6%)
KSE30 Increased By (0.7%)
AGHA 6.55 Increased By ▲ 0.23 (3.64%)
BECO 4.40 Increased By ▲ 0.13 (3.04%)
BML 62.43 Decreased By ▼ -0.02 (-0.03%)
BOP 31.38 Increased By ▲ 0.15 (0.48%)
CNERGY 11.79 Increased By ▲ 0.20 (1.73%)
CSIL 5.95 Increased By ▲ 0.23 (4.02%)
FCCL 61.12 Decreased By ▼ -0.42 (-0.68%)
FFL 14.88 Decreased By ▼ -0.14 (-0.93%)
FNEL 1.24 Increased By ▲ 0.01 (0.81%)
KEL 6.29 Increased By ▲ 0.03 (0.48%)
KOSM 6.00 Increased By ▲ 0.44 (7.91%)
LOTCHEM 24.85 Increased By ▲ 0.17 (0.69%)
MLCF 104.13 Increased By ▲ 0.05 (0.05%)
NBP 174.66 Decreased By ▼ -0.62 (-0.35%)
NCPL 52.83 Increased By ▲ 0.06 (0.11%)
NPL 54.48 Increased By ▲ 0.36 (0.67%)
OGDC 315.35 Increased By ▲ 1.96 (0.63%)
PACE 9.41 Increased By ▲ 0.21 (2.28%)
PAEL 35.62 Decreased By ▼ -0.18 (-0.5%)
PIBTL 13.71 Increased By ▲ 0.24 (1.78%)
PPL 223.38 Increased By ▲ 1.57 (0.71%)
PRL 80.79 Increased By ▲ 1.71 (2.16%)
PTC 47.15 Increased By ▲ 0.30 (0.64%)
SSGC 24.15 Increased By ▲ 0.28 (1.17%)
TBL 9.25 Decreased By ▼ -0.06 (-0.64%)
TELE 7.53 Increased By ▲ 0.14 (1.89%)
TPL 24.89 Decreased By ▼ -0.22 (-0.88%)
TPLP 12.88 Increased By ▲ 0.37 (2.96%)
TREET 26.10 Decreased By ▼ -0.15 (-0.57%)
TRG 53.75 Increased By ▲ 0.31 (0.58%)
World

Argentine regulator OK's Sputnik coronavirus vaccination for people over 60

  • The National Administration of Medicines, Food and Medical Technology, or ANMAT, Argentina's regulatory body.
  • the vaccine "is within an acceptable margin of safety and efficacy for the age group over 60 years."
Published Updated
By

BUENOS AIRES: Argentina has approved use of Russia's Sputnik coronavirus vaccination for people over the age of 60, the government of the South American country announced in a statement on Wednesday.

The National Administration of Medicines, Food and Medical Technology, or ANMAT, Argentina's regulatory body, said in the statement that the vaccine "is within an acceptable margin of safety and efficacy for the age group over 60 years."

Comments

Comments are closed for this article.